These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27133491)

  • 21. Endothelin receptor antagonism--new perspectives in the treatment of systemic sclerosis.
    Kowal-Bielecka O; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():291-3. PubMed ID: 16119689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient perspectives on patient-reported outcomes in multiple sclerosis treatment trajectories: A qualitative study of why, what, and how?
    Westergaard K; Skovgaard L; Magyari M; Kristiansen M
    Mult Scler Relat Disord; 2022 Feb; 58():103475. PubMed ID: 34995975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries.
    Willems LM; Kwakkenbos L; Leite CC; Thombs BD; van den Hoogen FH; Maia AC; Vliet Vlieland TP; van den Ende CH
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-88-93. PubMed ID: 25372793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease.
    Flick JA; Boyle JT; Tuchman DN; Athreya BH; Doughty RA
    Pediatrics; 1988 Jul; 82(1):107-11. PubMed ID: 3288952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difficulty with daily activities involving the lower extremities in people with systemic sclerosis.
    Poole JL; Brandenstein J
    Clin Rheumatol; 2016 Feb; 35(2):483-8. PubMed ID: 26660318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping strategies for activities of daily living in women whose hands affected by systemic sclerosis.
    Cinar FI; Unver V; Cinar M; Yilmaz S; Simsek I; Tosun N; Erdem H; Yilmaz F; Pay S; Dinc A
    J Clin Nurs; 2014 Jun; 23(11-12):1630-8. PubMed ID: 24330334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to change in systemic sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): shift in patient priorities over time.
    Nguyen C; Mouthon L; Mestre-Stanislas C; Rannou F; Bérezné A; Sanchez K; Papelard A; Revel M; Guillevin L; Poiraudeau S
    J Rheumatol; 2010 Feb; 37(2):359-64. PubMed ID: 20080914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring and managing appearance anxiety in patients with systemic sclerosis.
    Gholizadeh S; Meier A; Malcarne VL
    Expert Rev Clin Immunol; 2019 Apr; 15(4):341-346. PubMed ID: 30681381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Hearing Aid Technology on Outcomes in Daily Life I: The Patients' Perspective.
    Cox RM; Johnson JA; Xu J
    Ear Hear; 2016; 37(4):e224-37. PubMed ID: 26881981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis.
    Sandqvist G; Hesselstrand R
    Ann Rheum Dis; 2019 Jun; 78(6):855-857. PubMed ID: 30610065
    [No Abstract]   [Full Text] [Related]  

  • 35. Acquired brain injury secondary to systemic sclerosis: a case report.
    Gontkovsky ST
    Brain Inj; 2011; 25(11):1139-42. PubMed ID: 21870902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K; Smyth AE; Black CM; Denton CP
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
    Mills SD; Fox RS; Merz EL; Clements PJ; Kafaja S; Malcarne VL; Furst DE; Khanna D
    J Rheumatol; 2015 Sep; 42(9):1624-30. PubMed ID: 26034157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Reported Outcomes in Psoriatic Arthritis.
    Orbai AM; Ogdie A
    Rheum Dis Clin North Am; 2016 May; 42(2):265-83. PubMed ID: 27133489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding itch in systemic sclerosis in order to improve patient quality of life.
    Frech TM; Baron M
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):81-8. PubMed ID: 23910614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Patient-Reported Outcome Measures to Capture the Patient's Voice in Research and Care of Juvenile Idiopathic Arthritis.
    Hersh AO; Salimian PK; Weitzman ER
    Rheum Dis Clin North Am; 2016 May; 42(2):333-46. PubMed ID: 27133493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.